Analysts Say India Drug Makers Need To Focus On M&As At Home, Abroad
This article was originally published in PharmAsia News
Executive Summary
Analysts looking at India's drug industry are urging its members to start their own mergers and acquisitions with companies like Dr. Reddy's Laboratories, Glenmark, Lupin and Sun Pharma.